This compound is a chiral pharmaceutical intermediate featuring both an epoxide ring and a nitrobenzenesulfonate ester group. Its primary significance lies in its use as a synthetic building block for the preparation of enantiomerically pure pharmaceutical compounds.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 115314-17-5
(S)-(+)-Glycidyl-4-nitrobenzoate
Chiral building block for synthesis
(R)-(-)-Glycidyl-4-nitrobenzenesulfonate
chiral intermediate for active pharmaceutical ingredients
[(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(trifluoromethylsulfonyloxy)-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
pharmaceutical intermediate
(2-BOC-AMINOPHENYL)BORONIC ACID
Pharmaceutical intermediate for boronic acid synthesis
1-(tert-Butoxycarbonyl)-3-(cyanomethylene)azetidine
pharmaceutical research intermediate
2H,4H,5H,6H,7H,7aH-thieno[3,2-c]pyridin-2-one hydrochloride
pharmaceutical intermediate
Glycidyl 3-nitrobenzenesulfonate
Pharmaceutical intermediate
(2R)-(-)-Glycidyl tosylate
Pharmaceutical intermediate for chiral synthesis
[(2R)-oxiran-2-yl]methyl 3-nitrobenzenesulfonate
AIHIHVZYAAMDPM-MRVPVSSYSA-N
C1[C@@H](O1)COS(=O)(=O)C2=CC=CC(=C2)[N+](=O)[O-]